Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.

about

Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.

Item

http://www.wikidata.org/entity/Q47295153

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@en

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@nl

type

Item

label

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@en

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@nl

prefLabel

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@en

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@nl

P1476

Insulin-like growth factor 2 e ...... promoter-specific methylation.

@en

P2093

Alexander Marx

http://www.w3.org/2001/XMLSchema#string

Christian Sauer

http://www.w3.org/2001/XMLSchema#string

Djeda Belharazem

http://www.w3.org/2001/XMLSchema#string

Lutz Trojan

http://www.w3.org/2001/XMLSchema#string

Maurice S Michel

http://www.w3.org/2001/XMLSchema#string

Philipp Ströbel

http://www.w3.org/2001/XMLSchema#string

Stefan Küffer

http://www.w3.org/2001/XMLSchema#string

Tobias Gutting

http://www.w3.org/2001/XMLSchema#string

P2860

Vigilin interacts with CCCTC-binding factor (CTCF) and is involved in CTCF-dependent regulation of the imprinted genes Igf2 and H19

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer

CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus

JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles

Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis.

CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors.

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.

Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach

Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.

P304

256-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12164

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29239100

http://www.w3.org/2001/XMLSchema#string

P932

5792735

http://www.w3.org/2001/XMLSchema#string